Pacelli Steven Robert's Form 4 filing
Dexcom Inc (DXCM) · filed Jul 27, 2021
- Accession no.
- 0001093557-21-000182
- Filed
- Jul 27, 2021
- Trade date
- Jul 23, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $487.9K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pacelli Steven RobertCIK 0001359098 | Officer (Managing Dir., Dexcom Ventures) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 23, 2021 | Common Stock | SSaleDisposed | −279 | $450.82F2 | −$125,778.78 | 50,963 | Direct | |
| Jul 23, 2021 | Common Stock | SSaleDisposed | −800 | $452.65 | −$362,120 | 50,163 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $450.70 to $450.96. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.